Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial

2009 ◽  
pp. 1-6 ◽  
Author(s):  
Carolina Fux Otta ◽  
Myriam Wior ◽  
Gabriel Iraci ◽  
Raquel Kaplan ◽  
Diana Torres ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Lifestyle Intervention ◽  
Polycystic Ovary ◽  
Placebo Control Trial ◽  
Placebo Control ◽  
Ovary Syndrome ◽  
Double Blind ◽  
Endocrine Parameters

Licogliflozin versus Placebo in Women with Polycystic Ovary Syndrome (PCOS): A Randomised, Double-Blind, Phase 2 Trial

2021 ◽  
Author(s):  
Susanne Tan ◽  
Stanislav Ignatenko ◽  
Frank Wagner ◽  
Anuja Dokras ◽  
Jochen Seufert ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Phase 2 ◽  
Ovary Syndrome ◽  
Double Blind ◽  
Phase 2 Trial

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

2008 ◽  
Vol 89 (5) ◽  
pp. 1221-1228 ◽  
Author(s):  
Åsa Lindholm ◽  
Marie Bixo ◽  
Inger Björn ◽  
Pål Wölner-Hanssen ◽  
Mats Eliasson ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Weight Reduction ◽  
Polycystic Ovary ◽  
Controlled Trial ◽  
Ovary Syndrome ◽  
Double Blind ◽  
Double Blind Placebo

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility

Endocrine ◽  
2013 ◽  
Vol 44 (3) ◽  
pp. 583-590 ◽  
Author(s):  
Dimitrios Panidis ◽  
Konstantinos Tziomalos ◽  
Efstathios Papadakis ◽  
Christos Vosnakis ◽  
Panagiotis Chatzis ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Lifestyle Intervention ◽  
Polycystic Ovary ◽  
Ovary Syndrome
Sign in / Sign up

Export Citation Format

Share Document